Refine by
In Vitro Models Suppliers & Manufacturers
33 companies found
based inLeiden, NETHERLANDS
A leading pioneer in leveraging iPSC innovation for drug discovery. The catalyst with the requisite iPSC know-how and experience to empower innovators in drug discovery to advance their science relentlessly, consistently and efficiently. For the ...
Cortical neurons play a vital role in many neurodegenerative diseases, including Alzheimer’s disease. Human iPSC-derived cortical neurons can be co-cultured with astrocytes and microglia to model neurodegenerative diseases. Our team can ...
based inLausanne, SWITZERLAND
Since 2016, SUN bioscience has been revolutionizing Precision Health. Our mission is to empower personalized medicine by harnessing the potential of patient stem cells to identify the most effective drugs. At the heart of our groundbreaking efforts ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
based inSchlieren, SWITZERLAND
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...
An in vitro PDX model with in vivo-like heterogeneity. 3D InSight™ Tumor Microtissues from Patient-Derived Xenografts (PDX) are custom assay-ready 3D in vitro tumor models ...
based inMontreal, QUEBEC (CANADA)
eNUVIO three founders first met as graduate students in 2010, working together on an interdisciplinary collaboration between two university science labs in Montreal. At that time, it was obvious that they shared a strong interest for research tool ...
based inPrinceton, NEW JERSEY (USA)
The drug discovery and development process is long and expensive with more failures than successes. At Certara, we anticipate and address your critical drug discovery and development risks and decisions using biosimulation, technology and services. ...
Phoenix NLME lets you focus on your models, not the tools required to implement the models. Phoenix NLME is a population modeling and simulation software for scientists with varying levels of experience—from novice PK/PD scientists to the ...
based inBarcelona, SPAIN
Cytes Biotechnologies is a biotechnological company that offers products and services (CRO) based on tissue procurement, cell isolation and cell solutions for in vitro models addressed to the research community worldwide. The company’s main focus ...
The fresh human hepatocytes we offer are obtained and isolated from human donors for research purposes. These cells are a superior in-vitro model because they thrive in an environment closely resembling the in-vivo ...
based inAlameda, CALIFORNIA (USA)
Fluxion delivers advanced solutions that transform complex cell-based and cell-free assays. Leading labs across the globe rely on Fluxion's instruments, kits, and lab services to research novel biology, accelerate drug discovery, and tailor ...
Looking for a simple, fully integrated solution? The BioFlux DCIS integrates the BioFlux controller with a digital microscope, fluorescence, and two cameras. The easy-to-use live cell imaging system been designed with advanced capabilities to ...
based inBillerica, MASSACHUSETTS (USA)
Access Vascular is offering a suite of vascular access devices that use our novel, patented biomaterial featuring MIMIX™ technology which is designed to prevent the most common and costly complications in vascular access. Keep treatment moving ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
In vitro retinal disease modelling for retinal therapy. Newcells offers a fast and reliable in vitro safety and efficacy service for the evaluation of novel compounds for retinal therapy using ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
One of the main obstacles in drug development is how to deliver drugs effectively to target cells. In general, macromolecules such as proteins and mRNA cannot penetrate the cell membrane because the cell membrane has acquired protective mechanisms ...
based inSunnyvale, CALIFORNIA (USA)
JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers. JSR ...
based inIthaca, NEW YORK (USA)
iFyber is a preclinical contract research organization that offers custom research and development services to companies that operate at the interface of chemistry, biology, and materials science. iFyber is unique - we provide clients direct access ...
iFyber provides a suite of biofilm tests to verify the efficacy of antimicrobial medical devices and drugs. Biofilms are complex communities of microbes protected within a matrix of sugars, proteins, and extracellular DNA. These characteristics, in ...
based inSouthampton, UNITED KINGDOM
Synairgen is a drug discovery and development company founded by University of Southampton Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on COVID-19, severe asthma and COPD, discovers and develops ...
based inBillerica, MASSACHUSETTS (USA)
Pion is dedicated to providing unique scientific instruments and services that support scientists in making informed decisions about drug formulation, from research and development to manufacturing. Pion's products are globally utilized for various ...
The Scissor N3 is an advanced in vitro model designed to simulate the subcutaneous injection of biopharmaceuticals. This device is particularly useful during the formulation development phase, enabling researchers ...
based inBoston, MASSACHUSETTS (USA)
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro ...
Investigate mechanisms of colon inflammation and barrier disruption and evaluate the efficacy of anti-inflammatory drug candidates in an organoid-derived ...
based inParis, FRANCE
emka TECHNOLOGIES, now joined with SCIREQ, has been providing integrated systems for preclinical physiology, pharmacology & toxicology research for over 25 years. Our hardware and software are used daily, validated by major pharma companies and CROs ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Our mission at Alcyomics is to provide novel solutions for the assessment of safety and efficacy of pharmaceuticals, cosmetics and chemicals. As a service provider Alcyomics aspires to take the lead in providing unique screening services enabling ...
Development of complex and functional high-throughput in-vitro 3D tissue models for replicating disease states and high-throughput molecule ...
based inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
In the discovery of oncology therapeutics, Antibody-drug conjugates (ADCs) are rapidly gaining momentum, with hundreds of candidates advancing through clinical development. Whether your priority lies in assessing the epitope binding of your ...